FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

USA USA

Industries

  • Medicine ‎1
    • Pharmaceuticals ‎1

Contact Info

Location

Ufovax, LLC

  • 1Product
  • 1Types
  • 1Industry

About Company

Founded in early 2018, Ufovax, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology developed by Professor Jiang Zhu of Scripps Research to develop and commercialize B-cell focused, rapid antibody-eliciting, preventive vaccines for the most challenging diseases around the world.

Products

Coronavirus Vaccine Candidate

MEDICINE - PHARMACEUTICALS   |  COVID-19 VACCINE

Coronavirus Vaccine Candidate

Properties :

Immune system enhancement,Antibody generation

Application :

Coronavirus,COVID-19

Analytical Reports